SCHOTT Pharma AG & Co. KGaA
1SXP.F
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.56B
Close$
Share Statistics
| Market cap | $3.56 Billion |
|---|---|
| Enterprise Value | $3.77 Billion |
| Dividend Yield | $0.18 (0.76%) |
| Earnings per Share | $0.97 |
| Beta | 0.99 |
| Outstanding Shares | 149,338,461 |
Return
| Return on Equity | 13.71% |
|---|---|
| Return on Assets | 8.06% |
| Return on Invested Capital | 12.62% |
Valuation & Multiples
| P/E Ratio | 25.99 |
|---|---|
| PEG | -175.8 |
| Price to Sales | 3.94 |
| Price to Book Ratio | 3.94 |
| Enterprise Value to Revenue | 3.7 |
| Enterprise Value to EBIT | 23.97 |
| Enterprise Value to Net Income | 27 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.23 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$0.26
Average shareholder expectationRevenue Estimate
$273.22 M
Average shareholder expectationNext Earnings Call
Expected Date
December 10, 2026
EPS Estimate
$0.31
Average shareholder expectationRevenue Estimate
$275.77 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About SCHOTT Pharma AG & Co. KGaA
5,002 employees
CEO: Christian Mias Globally, SCHOTT Pharma AG & Co. KGaA specializes in the development, manufacturing, and distribution of sophisticated containment and delivery systems specifically designed for injectable pharmaceuticals, catering to the needs of the ph...